End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
784,000 KRW | +0.38% | -0.88% | +3.16% |
May. 06 | Samsung Group Firms Set to Invest in US-based Latus Bio | MT |
Apr. 25 | Samsung Bioepis Granted Approval to Market Autoimmune Treatment in Europe | MT |
ETFs positioned on Samsung Biologics Co.,Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.63% | 2 M€ | -14.14% | ||
0.92% | 11 M€ | -.--% | - | |
0.43% | 15 M€ | +16.55% | ||
0.15% | 454 M€ | +9.19% | - | |
0.15% | 2,867 M€ | +10.82% | - | |
0.15% | 153 M€ | +8.28% | - | |
0.13% | 4 M€ | -4.41% | - | |
0.07% | 11 M€ | +7.59% | ||
0.05% | 112 M€ | +5.62% | - | |
0.04% | 7 M€ | +6.66% | - | |
0.02% | 34 M€ | +9.13% | - | |
0.01% | 306 M€ | +6.92% | - | |
0.01% | 39 M€ | +5.99% | - | |
0.01% | 391 M€ | +9.47% | - | |
0.01% | 105 M€ | +4.11% | - | |
0.01% | 17 M€ | +3.30% | - | |
0.01% | 54 M€ | +1.52% | - | |
0.01% | 8 M€ | +1.26% | - | |
0.00% | 7 M€ | +0.11% | - | |
0.00% | 34 M€ | +4.39% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.16% | 41.08B | |
+0.10% | 91.42B | |
-11.28% | 34.26B | |
+53.99% | 25.27B | |
-9.48% | 12.81B | |
-12.25% | 11.6B | |
-44.00% | 11.42B | |
+5.77% | 9.16B | |
-6.90% | 8.22B | |
-7.26% | 7.06B |
- Stock Market
- Equities
- A207940 Stock
- Funds and ETFs Samsung Biologics Co.,Ltd.